KCM Investment Advisors LLC Boosts Holdings in CVS Health Corporation $CVS

KCM Investment Advisors LLC lifted its position in shares of CVS Health Corporation (NYSE:CVS) by 30.1% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 28,061 shares of the pharmacy operator’s stock after purchasing an additional 6,491 shares during the period. KCM Investment Advisors LLC’s holdings in CVS Health were worth $2,015,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in the company. Vanguard Group Inc. lifted its holdings in CVS Health by 1.5% in the 4th quarter. Vanguard Group Inc. now owns 120,709,530 shares of the pharmacy operator’s stock worth $9,579,508,000 after buying an additional 1,824,424 shares in the last quarter. State Street Corp boosted its holdings in CVS Health by 2.1% in the fourth quarter. State Street Corp now owns 60,183,743 shares of the pharmacy operator’s stock valued at $4,776,182,000 after purchasing an additional 1,245,457 shares during the last quarter. Capital International Investors grew its stake in CVS Health by 3.4% during the 4th quarter. Capital International Investors now owns 27,592,356 shares of the pharmacy operator’s stock valued at $2,189,793,000 after purchasing an additional 900,153 shares in the last quarter. Norges Bank purchased a new stake in CVS Health during the 4th quarter worth approximately $1,666,265,000. Finally, Morgan Stanley raised its position in shares of CVS Health by 6.3% in the 4th quarter. Morgan Stanley now owns 20,373,774 shares of the pharmacy operator’s stock valued at $1,616,863,000 after purchasing an additional 1,211,631 shares in the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.

CVS Health Stock Performance

Shares of CVS opened at $109.41 on Wednesday. The company has a debt-to-equity ratio of 0.78, a current ratio of 0.87 and a quick ratio of 0.66. CVS Health Corporation has a 12-month low of $58.99 and a 12-month high of $110.68. The business’s fifty day moving average price is $100.73 and its 200 day moving average price is $86.56. The stock has a market capitalization of $139.59 billion, a PE ratio of 48.20, a price-to-earnings-growth ratio of 1.05 and a beta of 0.61.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, May 6th. The pharmacy operator reported $2.57 earnings per share for the quarter, topping analysts’ consensus estimates of $2.21 by $0.36. CVS Health had a net margin of 0.72% and a return on equity of 11.88%. The company had revenue of $100.43 billion for the quarter, compared to analysts’ expectations of $94.99 billion. During the same period in the prior year, the company earned $2.25 earnings per share. The firm’s revenue was up 6.2% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 7.300-7.500 EPS. Equities research analysts forecast that CVS Health Corporation will post 7.46 EPS for the current year.

CVS Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, August 3rd. Shareholders of record on Thursday, July 23rd will be paid a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 2.4%. The ex-dividend date is Thursday, July 23rd. CVS Health’s payout ratio is presently 117.18%.

Key CVS Health News

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: CVS has recently outperformed the broader market, reflecting strong investor momentum following its earnings beat and improving outlook. CVS Health Laps the Stock Market
• Positive Sentiment: Analyst coverage remains broadly constructive, with CVS included among healthcare companies showing favorable indicators ahead of second-quarter 2026 results. Expectations for an earnings beat could support the stock, although execution and margins remain important. Zacks Analyst Blog Highlights CVS Health
• Positive Sentiment: CVS is again identified as one of four medical stocks positioned for a potential second-quarter earnings beat, supported by resilient demand for healthcare products and services. Medical Stocks With the Right Setup for Earnings Beats
• Positive Sentiment: Kate Farms is expanding distribution of its high-protein nutrition shakes into CVS stores, adding another health and wellness product that could modestly increase customer traffic and product breadth. Kate Farms Expands Distribution Into CVS
• Neutral Sentiment: Humana’s upcoming results are drawing attention to Medicare Advantage medical costs and guidance. A favorable report could reinforce sentiment toward health insurers, while cost pressure could have the opposite effect for CVS. Humana Earnings Face High Expectations
• Neutral Sentiment: CVS also highlighted community investments in Massachusetts, caregiving initiatives and recognition for supply-chain work. These support the company’s reputation but are unlikely to materially change near-term earnings. CVS Health Helping Strengthen Communities

Wall Street Analyst Weigh In

CVS has been the subject of a number of recent analyst reports. JPMorgan Chase & Co. raised their price target on shares of CVS Health from $101.00 to $111.00 and gave the stock an “overweight” rating in a research report on Tuesday, May 12th. Royal Bank Of Canada increased their price objective on shares of CVS Health from $107.00 to $113.00 and gave the company an “outperform” rating in a research note on Thursday, July 9th. Morgan Stanley raised their price objective on shares of CVS Health from $106.00 to $111.00 and gave the stock an “overweight” rating in a report on Thursday, June 4th. Deutsche Bank Aktiengesellschaft boosted their target price on shares of CVS Health from $88.00 to $92.00 and gave the stock a “buy” rating in a research report on Thursday, May 7th. Finally, Bank of America increased their price target on shares of CVS Health from $100.00 to $110.00 and gave the stock a “buy” rating in a research report on Monday, June 22nd. Twenty-one investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $105.67.

Insider Activity at CVS Health

In other news, Director Larry Robbins sold 1,983,538 shares of the stock in a transaction that occurred on Tuesday, May 19th. The stock was sold at an average price of $94.45, for a total transaction of $187,345,164.10. Following the sale, the director directly owned 6,213,261 shares in the company, valued at approximately $586,842,501.45. This represents a 24.20% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Tilak Mandadi sold 69,551 shares of the stock in a transaction on Friday, May 8th. The stock was sold at an average price of $89.58, for a total value of $6,230,378.58. Following the completion of the sale, the executive vice president directly owned 10,133 shares in the company, valued at $907,714.14. This represents a 87.28% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 3,441,551 shares of company stock valued at $323,703,977 over the last ninety days. Corporate insiders own 0.85% of the company’s stock.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.